Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Wave Life Sciences (WVE) Receivables - Other (2018 - 2021)

Wave Life Sciences (WVE) has disclosed Receivables - Other for 4 consecutive years, with $30.0 million as the latest value for Q1 2021.

  • For Q1 2021, Receivables - Other changed 0.0% year-over-year to $30.0 million; the TTM value through Mar 2021 reached $30.0 million, changed 0.0%, while the annual FY2020 figure was $30.0 million, 40.0% down from the prior year.
  • Receivables - Other hit $30.0 million in Q1 2021 for Wave Life Sciences, roughly flat from $30.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $60.0 million in Q2 2018 and bottomed at $10.0 million in Q3 2018.
  • Average Receivables - Other over 4 years is $38.3 million, with a median of $30.0 million recorded in 2020.
  • Year-over-year, Receivables - Other soared 100.0% in 2019 and then tumbled 50.0% in 2020.
  • Wave Life Sciences' Receivables - Other stood at $60.0 million in 2018, then decreased by 16.67% to $50.0 million in 2019, then tumbled by 40.0% to $30.0 million in 2020, then changed by 0.0% to $30.0 million in 2021.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $30.0 million, $30.0 million, and $30.0 million for Q1 2021, Q4 2020, and Q3 2020 respectively.